LifeMDLFMD
About: LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Employees: 232
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
96% more call options, than puts
Call options by funds: $828K | Put options by funds: $423K
17% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 29
0.75% less ownership
Funds ownership: 40.57% [Q2] → 39.82% (-0.75%) [Q3]
3% less funds holding
Funds holding: 103 [Q2] → 100 (-3) [Q3]
13% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 23
22% less capital invested
Capital invested by funds: $116M [Q2] → $89.9M (-$25.7M) [Q3]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Lake Street Brooks O'Neil 45% 1-year accuracy 5 / 11 met price target | 138%upside $12 | Buy Initiated | 10 Dec 2024 |
Mizuho Steven Valiquette 20% 1-year accuracy 1 / 5 met price target | 39%upside $7 | Neutral Initiated | 4 Dec 2024 |
HC Wainwright & Co. Yi Chen 39% 1-year accuracy 60 / 154 met price target | 138%upside $12 | Buy Reiterated | 11 Nov 2024 |
Financial journalist opinion
